Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Basic and Clinical Physiology and Pharmacology

Editor-in-Chief: Horowitz, Michal

Editorial Board: Das, Kusal K. / Epstein, Yoram / S. Gershon MD, Elliot / Haim, Abraham / Kodesh , Einat / Kohen, Ron / Lichtstein, David / Maloyan, Alina / Mechoulam, Raphael / Roth, Joachim / Schneider, Suzanne / Shohami, Esther / Sohmer, Haim / Yoshikawa, Toshikazu

6 Issues per year


CiteScore 2016: 1.01

SCImago Journal Rank (SJR) 2016: 0.349
Source Normalized Impact per Paper (SNIP) 2016: 0.495

Online
ISSN
2191-0286
See all formats and pricing
More options …
Volume 24, Issue 1

Issues

Protective role of ferulic acid on carbon tetrachloride-induced hyperlipidemia and histological alterations in experimental rats

Srinivasan Marimuthu / Ram Sudheer Adluri
  • Molecular Cardiology and Angiogenesis Laboratory, Department of Surgery, Health Center, University of Connecticut, Farmington, CT, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Rukkumani Rajagopalan
  • Department of Biochemistry and Molecular Biology, Pondicherry University, Kalapet, Pondicherry, India
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Venugopal Padmanabhan Menon
  • Corresponding author
  • Faculty of Science, Department of Biochemistry and Biotechnology, Annamalai University, Annamalai Nagar, Chidambaram, India
  • Centre for Micronutrient Research (Johns Hopkins University, USA Funded Center), Annamalai University, Annamalai Nagar 608 002, Tamil Nadu, India
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2012-12-12 | DOI: https://doi.org/10.1515/jbcpp-2012-0053

Abstract

Background: The present study aimed to evaluate the antihyperlipidemic effect of ferulic acid (FA) on carbon tetrachloride (CCl4)-treated rats.

Methods: Female albino rats of the Wistar strain were used in the present study. The rats were divided into four groups: groups 1 and 4 received physiological saline (3 mL/kg body weight/week) by subcutaneous injection, whereas groups 2 and 3 received a subcutaneous injection of CCl4 (3 mL/kg body weight/week) for a total period of 12 weeks. In addition, groups 3 and 4 were administered FA (20 mL/kg body weight) every day for the last 90 days.

Results: The results showed significantly (p≤0.05) elevated levels of cholesterol, triglycerides (TG), and free fatty acids (FFA) in the liver and kidney of CCl4-treated rats as compared with those of the controls. In addition, the levels of cholesterol, FFA, phospholipids (PL), and TG were elevated significantly in the circulation. Administration of FA effectively reduced these levels of lipids in the plasma, liver, and kidney of CCl4-treated rats. The PL level was significantly decreased in the liver and kidney of CCl4-treated rats and was positively modulated by FA treatment. Our histopathological observations were also in correlation with the biochemical parameters.

Conclusions: From the results obtained, we could conclude that FA effectively protects the system against hyperlipidemia and may be an effective therapeutic agent for the treatment of this disorder.

Keywords: antihyperlipidemia; antioxidants; CCl4; ferulic acid; histopathology; lipids

About the article

Corresponding author: Dr. Venugopal Padmanabhan Menon, Co-ordinator and Advisor, Centre for Micronutrient Research (Johns Hopkins University, USA Funded Center), Annamalai University, Annamalai Nagar 608 002, Tamil Nadu, India, Phone: +91 04144-238343, Fax: +91 04144-238343


Received: 2012-09-19

Accepted: 2012-11-12

Published Online: 2012-12-12

Published in Print: 2013-02-01


Citation Information: Journal of Basic and Clinical Physiology and Pharmacology, Volume 24, Issue 1, Pages 59–66, ISSN (Online) 2191-0286, ISSN (Print) 0792-6855, DOI: https://doi.org/10.1515/jbcpp-2012-0053.

Export Citation

©2013 by Walter de Gruyter Berlin Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Mohammad Mazani, Yavar Mahmoodzadeh, and Lotfollah Rezagolizadeh
Scientific Journal of Kurdistan University of Medical Sciences, 2018, Volume 23, Number 2, Page 70
[3]
Khaled Bellassoued, Anis Ben Hsouna, Khaled Athmouni, Jos van Pelt, Fatma Makni Ayadi, Tarek Rebai, and Abdelfattah Elfeki
Lipids in Health and Disease, 2018, Volume 17, Number 1
[4]
Yavar Mahmoodzadeh, Mohammad Mazani, and Lotfollah Rezagholizadeh
Toxicology Reports, 2017
[5]
Cristina Perez-Ternero, Maria Alvarez de Sotomayor, and Maria Dolores Herrera
Journal of Functional Foods, 2017, Volume 32, Page 58
[6]
Manoj Aswar and Vijay Patil
Inflammopharmacology, 2016, Volume 24, Number 4, Page 181
[7]
Jie-Qiong Ma, Jie Ding, Hai Zhao, and Chan-Min Liu
Basic & Clinical Pharmacology & Toxicology, 2014, Volume 115, Number 5, Page 389

Comments (0)

Please log in or register to comment.
Log in